The challenge of rational development of complex natural products as cancer therapeutics.
White
Jeffrey
J
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001688:Biological Products / Q000592:standards* / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D002356:Cartilage; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D014020:Tissue Extracts / Q000592:standards / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D020533:Angiogenesis Inhibitors; D001688:Biological Products; D014020:Tissue Extracts; C111481:shark cartilage extract